DOSSIER · 13F Holders · Q3 2026
AIXC
QUALIGEN THERAPEUTICS INC
17 institutions still hold QUALIGEN THERAPEUTICS INC as of Q3 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 74754R301·17 13F holders·last filed Sep 30, 2026
AI Holders Summary · Q3 2026
17 institutions reported AIXC in Q3 2026. GEODE CAPITAL MANAGEMENT, LLC leads at 45.7% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.